High prevalence of abnormal alanine and aspartate aminotransferases in a "worried-well" population in the United Kingdom: Rationale for a liver screening program?

Hepatology

Volumn 48, Issue 5, 2008, Pages 1729-1730

  García Romero, Diana ^a,b   Anastassiou, J ^a   Hart, Gillian ^c   Mookerjee, Rajeshwar ^a   Jalan, Rajiv ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c YorkTest Laboratories Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC LIVER DISEASE; COLORIMETRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; LETTER; LIVER FUNCTION TEST; MASS SCREENING; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SEX DIFFERENCE; UNITED KINGDOM; ADULT; AGED; BLOOD; FEMALE; LIVER DISEASE; MALE; MIDDLE AGED; MORTALITY; NOTE; SURVIVAL;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FEMALE; GREAT BRITAIN; HUMANS; LIVER DISEASES; MALE; MASS SCREENING; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 56149114505     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22553     Document Type: Letter

References (10)

1. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd. Serum aminotransferase activity and mortality risk in a United States community. HEPATOLOGY 2008;47:880-887.
2. LiverCheck test. YorkTest Laboratories, www.yorktest.com.
3. Neuschwander-Tetri BA, Ünalp, A, Creer MH. Influence of local reference populations on upper limits ofnormal for serum alanine aminotransferase levels. Arch Intern Med 2008;168:663-666.
4. Prad D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-10.
5. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: Prospective cohort study. BMJ 2004;328:983.
6. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine amino-transferase in chronic hepatitis: Relationship to cirrhosis. Gastroenterology 1988;95:734-739.
7. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44-48.
8. Kim WR, Flamm SL, Di Bisceglie M, Bodenheimer HC. Serum activity of alanine aminotransferase as an indicator of health and disease. HEPATOLOGY 2008;47:1363-1370.
9. Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008;134:1376-1384.
10. Puoti C, Bellis L, Galossi A, Guarisco R, Nicodemo S, Spilabotti L, et al. Antiviral treatment of HCV carriers with persistently normal ALT levels. Mini Rev Med Chem 2008;8:150-152.